scholarly journals Loeffler Endocarditis: A Manifestation of Hypereosinophilic Syndrome

CASE ◽  
2020 ◽  
Vol 4 (2) ◽  
pp. 74-77
Author(s):  
Michael Arustamyan ◽  
Jamael Hoosain ◽  
Jennifer Mattson ◽  
Syed Farhan Hasni ◽  
Sung-Hae Cho ◽  
...  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Qian Zhang ◽  
Daoyuan Si ◽  
Zhongfan Zhang ◽  
Wenqi Zhang

Abstract Background Loeffler endocarditis is a relatively rare and potentially life-threatening heart disease. This study aimed to identify the characteristic features of Loeffler endocarditis with intracardiac thrombus on a background of hypereosinophilic syndrome (HES). Case presentation We described a 57-year-old woman with Loeffler endocarditis and intracardiac thrombus initially presenting with neurological symptoms, who had an embolic stroke in the setting of HES. After cardiac magnetic resonance (CMR), corticosteroids and warfarin were administered to control eosinophilia and thrombi, respectively. During a 10-month follow-up, the patient performed relatively well, with no adverse events. We also systematically searched PubMed and Embase for cases of Loeffler endocarditis with intracardiac thrombus published until July 2021. A total of 32 studies were eligible and included in our analysis. Further, 36.4% of recruited patients developed thromboembolic complications, and the mortality rate was relatively high (27.3%). CMR was a powerful noninvasive modality in providing diagnostic and follow-up information in these patients. Steroids were administered in 81.8% of patients, achieving a rapid decrease in the eosinophil count. Also, 69.7% of patients were treated with anticoagulant therapy, and the thrombus was completely resolved in 42.4% of patients. Heart failure and patients not treated with anticoagulation were associated with poor outcomes. Conclusions Cardiac involvement in HES, especially Loeffler endocarditis with intracardiac thrombus, carries a pessimistic prognosis and significant mortality. Early steroids and anticoagulation therapy may be beneficial once a working diagnosis is established. Further studies are needed to provide evidence-based evidence for managing this uncommon manifestation of HES.


2017 ◽  
Vol 10 ◽  
pp. 117954761772364 ◽  
Author(s):  
Amit Alam ◽  
Shankar Thampi ◽  
Shahryar G Saba ◽  
Rita Jermyn

Loeffler endocarditis is a rare restrictive cardiomyopathy caused by abnormal endomyocardial infiltration of eosinophils, with subsequent tissue damage from degranulation, eventually leading to fibrosis. Although an uncommon entity, it is still a disease with significant morbidity and mortality. Often identified only at late stages, treatment options are limited once fibrosis occurs, usually requiring heart failure medications or surgical intervention. We present a unique case of a woman with remote history of hypereosinophilic syndrome, attributed to treatment of rheumatoid arthritis with infliximab, who presented with symptoms of heart failure refractory to medical management and was found to have Loeffler endocarditis. The severe progression of the disease required surgical intervention with endocardial stripping to treat the right-sided diastolic heart failure.


2017 ◽  
Vol 12 (4) ◽  
pp. 141-141
Author(s):  
Urška Dolores Breskvar Kač ◽  
Ljupka Dimitrovska ◽  
Jana Ambrožič ◽  
Mojca Bervar

2019 ◽  
Author(s):  
G Yavuz ◽  
T Kauke ◽  
OM Glück ◽  
T Weig ◽  
K Milger-Kneidinger ◽  
...  

1993 ◽  
Vol 29 (4) ◽  
pp. 757
Author(s):  
Gi Beom Kim ◽  
Ok Hwoa Kim ◽  
Jong Min Lee ◽  
Yeong Soon Sung ◽  
Duk Sik Kang

1997 ◽  
Vol 37 (4) ◽  
pp. 673 ◽  
Author(s):  
Kyung Sook Kim ◽  
Moon Gyu Lee ◽  
Young Chul Won ◽  
Eun Hye Lee ◽  
Han Na Noh ◽  
...  

1991 ◽  
Vol 53 (3) ◽  
pp. 525-529 ◽  
Author(s):  
Kenichi MORI ◽  
Mamoru KOHDA ◽  
Yasuji MORI ◽  
Hiroaki UEKI ◽  
Masahiko KUMAGAI

Sign in / Sign up

Export Citation Format

Share Document